Botensilimab, CAS 2408310-37-0

Product Description: Botensilimab (AGEN 1181), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Delepine C, et, al. 470 Botensilimab, an Fc-enhanced CTLA-4 antibody, enhances innate and adaptive immune activation to promote superior anti-tumor immunity in cold and I-O refractory tumors FREE.

CAS Number: 2408310-37-0

Molecular Weight: N/A

Compound Purity: 97.18

Research Area: Cancer

Solubility: H2O

Target: CTLA-4

• Artikelnummer: MEXHY-P99484-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99484-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated